Education
About Us
Working with TipRanks
Follow Us
LENSAR (LNSR)
NASDAQ:LNSR
LNSR Stock Chart & Stats
$11.61
-$0.54(-6.29%)
At close: 4:00 PM EST
$11.61
-$0.54(-6.29%)
Day’s Range― - ―
52-Week Range$8.96 - $17.31
Previous CloseN/A
Volume40.10K
Average Volume (3M)58.95K
Market Cap
$152.05M
Enterprise Value$147.30M
Total Cash (Recent Filing)$16.87M
Total Debt (Recent Filing)$2.88M
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Mar 10, 2026EPS Estimate
-0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding11,944,546
10 Day Avg. Volume51,870
30 Day Avg. Volume58,950
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)5.52
Price to Sales (P/S)1.92
P/FCF Ratio-42.36
Enterprise Value/Market Cap0.97
Enterprise Value/Revenue2.49
Enterprise Value/Gross Profit5.44
Enterprise Value/Ebitda-11.65
Forecast
1Y Price Target
$15.00Price Target Upside29.20% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
AcquisitionThe announced acquisition by Alcon is seen as a positive outcome for both Lensar and Alcon, with Lensar experiencing strong adoption of its ALLY System in the cataract surgery market.
Market ExpansionLNSR highlighted that ~75% of US FY24 placements have come from new customers, indicating strong market expansion and competitive positioning.
Bears Say
Fair ValuationThe stock is rated as Neutral because the implied takeout value is seen as fairly valued, indicating limited upside potential.
Growth ChallengesLensar is required to achieve substantial procedure growth to meet the terms of the acquisition agreement, which may pose challenges.
LENSAR News
LNSR FAQ
What was LENSAR’s price range in the past 12 months?
LENSAR lowest stock price was $8.96 and its highest was $17.31 in the past 12 months.
What is LENSAR’s market cap?
LENSAR’s market cap is $152.05M.
When is LENSAR’s upcoming earnings report date?
LENSAR’s upcoming earnings report date is Mar 10, 2026 which is in 36 days.
How were LENSAR’s earnings last quarter?
LENSAR released its earnings results on Nov 06, 2025. The company reported -$0.31 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.31.
Is LENSAR overvalued?
According to Wall Street analysts LENSAR’s price is currently Undervalued.
Does LENSAR pay dividends?
LENSAR does not currently pay dividends.
What is LENSAR’s EPS estimate?
LENSAR’s EPS estimate is -0.07.
How many shares outstanding does LENSAR have?
LENSAR has 11,944,546 shares outstanding.
What happened to LENSAR’s price movement after its last earnings report?
LENSAR reported an EPS of -$0.31 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.626%.
Which hedge fund is a major shareholder of LENSAR?
Currently, no hedge funds are holding shares in LNSR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
LENSAR Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$15.00 (29.20% Upside)
$15.00 (29.20% Upside)
Blogger Sentiment
Bullish
LNSR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 214.1K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
56.49%
12-Months-Change
Fundamentals
Return on Equity
-422.35%
Trailing 12-Months
Asset Growth
13.20%
Trailing 12-Months
Company Description
LENSAR
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
LNSR Stock 12 Month Forecast
Average Price Target
$15.00
▲(29.20% Upside)
Technical Analysis
Ownership Overview
40.96% Insiders
8.22% Mutual Funds
20.40% Other Institutional Investors
23.49% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---